CRO

INC launches new consulting unit; Chemi says a saboteur got it banned in Canada;

> INC Research has launched a new business unit, Research Strategic Advisory Services, aimed to consult with drugmakers as they plot paths for development and commercialization. News

> Catalent is extending its partnership with Exelixis to supply the cancer drug CometriqT in the U.S. Story

> U.K. CMO Aesica Pharmaceutical says partnering with academia is getting more and more important for contractors looking to meet the changing demands of pharma clients. Article

> As drug delivery technology moves forward into new frontiers, CROs and CMOs are driving some of the most innovative thinking, Life Science Leader reports. More

> Canada's Chemi Pharmaceutical is blaming a sabotaging former employee for falsified results that got it suspended by the country's regulatory outfit. Item

> QPS has launched a joint venture with Intellim to create a new Japanese CRO. Report